FDA Inspection 969113 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 1000138168

The FDA completed an inspection of New York Blood Center Enterprises on April 21, 2016 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 21, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Hyde Park, NY (United States)